April 29, 2021

EuropaBio on NGT study: A positive step towards delivering innovation

EuropaBio welcomes the in-depth opinion of the European Group on Ethics on the uses of genome editing and thanks the Group for raising the awareness of a technology which will enable the development of many solutions for healthy people and planet.
April 27, 2021

EuropaBio proposes how to increase competitiveness of biotechnology sector in the EU

EuropaBio welcomes the in-depth opinion of the European Group on Ethics on the uses of genome editing and thanks the Group for raising the awareness of a technology which will enable the development of many solutions for healthy people and planet.
May 28, 2018

SPC waiver risks downgrading the EU as a hub for Health Innovation

As an association that has manufacturers of both originator and biosimilar medicines as members, EuropaBio strongly doubts that the promises of today’s Commission proposal outweigh the risks of losing investment in new medicines.
March 3, 2017

EuropaBio statement on European Parliament report on EU options for improving access to medicines

EuropaBio notes the adoption by the European Parliament of the report on EU options for improving patient access to medicines on 2 March 2017, in Brussels.
Become a member